Barrie Kellam

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 38

Top Venues

Journal of medicinal chemistry

Science signaling

Pharmacology research & perspectives

ACS medicinal chemistry letters

University of Nottingham

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Nottingham Aug 01 2013

United Kingdom

Professor of Medicinal Chemistry :: School of Pharmacy

Publications

Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Foteini Patera, Sarah J Mistry, Nicholas D Kindon, Eleonora Comeo, Joëlle Goulding, Barrie Kellam, Laura E Kilpatrick, Hester Ann Franks, Stephen J Hill
A novel and selective fluorescent ligand for the study of adenosine A 2B receptors. Pharmacology research & perspectives 12 (4) (2024)
Eleonora Comeo, Joëlle Goulding, Chia-Yang Lin, Marleen Groenen, Jeanette Woolard, Nicholas D Kindon, Clare R Harwood, Simon Platt, Stephen J Briddon, Laura E Kilpatrick, Peter J Scammells, Stephen J Hill, Barrie Kellam
Ligand-Directed Labeling of the Adenosine A 1 Receptor in Living Cells. Journal of medicinal chemistry 67 (14) (2024)
Fadi Soukarieh, Alaa Mashabi, William Richardson, Eduard Vico Oton, Manuel Romero, Jean-Frédéric Dubern, Shaun N Robertson, Simone Lucanto, Zoe Markham-Lee, Tomás Sou, Irena Kukavica-Ibrulj, Roger C Levesque, Christel A S Bergstrom, Nigel Halliday, Barrie Kellam, Jonas Emsley, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Cámara
Design, Synthesis, and Evaluation of New 1 H -Benzo[ d ]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. Journal of medicinal chemistry 67 (2) (2024)
Fadi Soukarieh, Alaa Mashabi, William Richardson, Eduard Vico Oton, Manuel Romero, Jean-Frédéric Dubern, Shaun N Robertson, Simone Lucanto, Zoe Markham-Lee, Tomás Sou, Irena Kukavica-Ibrulj, Roger C Levesque, Christel A S Bergstrom, Nigel Halliday, Barrie Kellam, Jonas Emsley, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Cámara
Design, Synthesis, and Evaluation of New 1 H -Benzo[ d ]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. Journal of medicinal chemistry 67 (2) (2024)
Fadi Soukarieh, Alaa Mashabi, William Richardson, Eduard Vico Oton, Manuel Romero, Jean-Frédéric Dubern, Shaun N Robertson, Simone Lucanto, Zoe Markham-Lee, Tomás Sou, Irena Kukavica-Ibrulj, Roger C Levesque, Christel A S Bergstrom, Nigel Halliday, Barrie Kellam, Jonas Emsley, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Cámara
Design, Synthesis, and Evaluation of New 1 H -Benzo[ d ]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. Journal of medicinal chemistry 67 (2) (2024)
Foteini Patera, Sarah J Mistry, Nicholas D Kindon, Eleonora Comeo, Joëlle Goulding, Barrie Kellam, Laura E Kilpatrick, Hester Ann Franks, Stephen J Hill
A novel and selective fluorescent ligand for the study of adenosine A 2B receptors. Pharmacology research & perspectives 12 (4) (2024)
Fadi Soukarieh, Alaa Mashabi, William Richardson, Eduard Vico Oton, Manuel Romero, Jean-Frédéric Dubern, Shaun N Robertson, Simone Lucanto, Zoe Markham-Lee, Tomás Sou, Irena Kukavica-Ibrulj, Roger C Levesque, Christel A S Bergstrom, Nigel Halliday, Barrie Kellam, Jonas Emsley, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Cámara
Design, Synthesis, and Evaluation of New 1 H -Benzo[ d ]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. Journal of medicinal chemistry 67 (2) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Eleonora Comeo, Joëlle Goulding, Chia-Yang Lin, Marleen Groenen, Jeanette Woolard, Nicholas D Kindon, Clare R Harwood, Simon Platt, Stephen J Briddon, Laura E Kilpatrick, Peter J Scammells, Stephen J Hill, Barrie Kellam
Ligand-Directed Labeling of the Adenosine A 1 Receptor in Living Cells. Journal of medicinal chemistry 67 (14) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Eleonora Comeo, Joëlle Goulding, Chia-Yang Lin, Marleen Groenen, Jeanette Woolard, Nicholas D Kindon, Clare R Harwood, Simon Platt, Stephen J Briddon, Laura E Kilpatrick, Peter J Scammells, Stephen J Hill, Barrie Kellam
Ligand-Directed Labeling of the Adenosine A 1 Receptor in Living Cells. Journal of medicinal chemistry 67 (14) (2024)
Fadi Soukarieh, Alaa Mashabi, William Richardson, Eduard Vico Oton, Manuel Romero, Jean-Frédéric Dubern, Shaun N Robertson, Simone Lucanto, Zoe Markham-Lee, Tomás Sou, Irena Kukavica-Ibrulj, Roger C Levesque, Christel A S Bergstrom, Nigel Halliday, Barrie Kellam, Jonas Emsley, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Cámara
Design, Synthesis, and Evaluation of New 1 H -Benzo[ d ]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. Journal of medicinal chemistry (2024)
Eleonora Comeo, Joëlle Goulding, Chia-Yang Lin, Marleen Groenen, Jeanette Woolard, Nicholas D Kindon, Clare R Harwood, Simon Platt, Stephen J Briddon, Laura E Kilpatrick, Peter J Scammells, Stephen J Hill, Barrie Kellam
Ligand-Directed Labeling of the Adenosine A 1 Receptor in Living Cells. Journal of medicinal chemistry 67 (14) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Eleonora Comeo, Joëlle Goulding, Chia-Yang Lin, Marleen Groenen, Jeanette Woolard, Nicholas D Kindon, Clare R Harwood, Simon Platt, Stephen J Briddon, Laura E Kilpatrick, Peter J Scammells, Stephen J Hill, Barrie Kellam
Ligand-Directed Labeling of the Adenosine A 1 Receptor in Living Cells. Journal of medicinal chemistry (2024)
Sebastian Dekkers, Dehan Comez, Noemi Karsai, Marta Arimont-Segura, Meritxell Canals, Birgit Caspar, Chris de Graaf, Laura E Kilpatrick, Rob Leurs, Barrie Kellam, Stephen J Hill, Stephen J Briddon, Michael J Stocks
Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3). ACS medicinal chemistry letters 15 (1) (2023)
Sebastian Dekkers, Birgit Caspar, Joëlle Goulding, Nicholas D Kindon, Laura E Kilpatrick, Leigh A Stoddart, Stephen J Briddon, Barrie Kellam, Stephen J Hill, Michael J Stocks
Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor. Journal of medicinal chemistry (2023)
Sebastian Dekkers, Dehan Comez, Noemi Karsai, Marta Arimont-Segura, Meritxell Canals, Birgit Caspar, Chris de Graaf, Laura E Kilpatrick, Rob Leurs, Barrie Kellam, Stephen J Hill, Stephen J Briddon, Michael J Stocks
Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3). ACS medicinal chemistry letters 15 (1) (2023)
Alessandra Travanut, Patrícia F Monteiro, Sean Smith, Steven M Howdle, Anna M Grabowska, Barrie Kellam, Michael A R Meier, Cameron Alexander
Passerini chemistries for synthesis of polymer pro-drug and polymersome drug delivery nanoparticles. Journal of materials chemistry. B 10 (20) (2022)
Akosua B Anane-Adjei, Nicholas L Fletcher, Robert J Cavanagh, Zachary H Houston, Theodore Crawford, Amanda K Pearce, Vincenzo Taresco, Alison A Ritchie, Phillip Clarke, Anna M Grabowska, Paul R Gellert, Marianne B Ashford, Barrie Kellam, Kristofer J Thurecht, Cameron Alexander
Synthesis, characterisation and evaluation of hyperbranched N -(2-hydroxypropyl) methacrylamides for transport and delivery in pancreatic cell lines in vitro and in vivo . Biomaterials science 10 (9) (2022)
Joëlle Goulding, Sarah J Mistry, Mark Soave, Jeanette Woolard, Stephen J Briddon, Carl W White, Barrie Kellam, Stephen J Hill
Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2-adrenoceptor in CRISPR/Cas9 genome-edited HEK293T cells at low expression levels. Pharmacology research & perspectives 9 (3) (2022)
Zhi Yuan Kok, Leigh A Stoddart, Sarah J Mistry, Tamara A M Mocking, Henry F Vischer, Rob Leurs, Stephen J Hill, Shailesh N Mistry, Barrie Kellam
Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H 1 Receptor. Journal of medicinal chemistry 65 (12) (2022)
Fadi Soukarieh, Alaa Mashabi, William Richardson, Eduard Vico Oton, Manuel Romero, Shaun N Roberston, Scott Grossman, Tomas Sou, Ruiling Liu, Nigel Halliday, Irena Kukavica-Ibrulj, Roger C Levesque, Christel A S Bergstrom, Barrie Kellam, Jonas Emsley, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Cámara
Design and Evaluation of New Quinazolin-4(3H)-one Derived PqsR Antagonists as Quorum Sensing Quenchers in Pseudomonas aeruginosa. ACS infectious diseases 7 (9) (2021)
Eleonora Comeo, Phuc Trinh, Anh T Nguyen, Cameron J Nowell, Nicholas D Kindon, Mark Soave, Leigh A Stoddart, Jonathan M White, Stephen J Hill, Barrie Kellam, Michelle L Halls, Lauren T May, Peter J Scammells
Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells. Journal of medicinal chemistry 64 (10) (2021)
Foteini-Nafsika Damaskinaki, Luis A Moran, Angel Garcia, Barrie Kellam, Steve P Watson
Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2. Platelets 32 (6) (2021)
Eleonora Comeo, Nicholas D Kindon, Mark Soave, Leigh A Stoddart, Laura E Kilpatrick, Peter J Scammells, Stephen J Hill, Barrie Kellam
Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A2A Receptor. Journal of medicinal chemistry 63 (5) (2020)
Leigh A Stoddart, Nicholas D Kindon, Omolade Otun, Clare R Harwood, Foteini Patera, Dmitry B Veprintsev, Jeanette Woolard, Stephen J Briddon, Hester Ann Franks, Stephen J Hill, Barrie Kellam
Ligand-directed covalent labelling of a GPCR with a fluorescent tag in live cells. Communications biology 3 (1) (2020)
Alexander Gillis, Arisbel B Gondin, Andrea Kliewer, Julie Sanchez, Herman D Lim, Claudia Alamein, Preeti Manandhar, Marina J Santiago, Sebastian Fritzwanker, Frank Schmiedel, Timothy A Katte, Tristan A Reekie, Natasha L Grimsey, Michael Kassiou, Barrie Kellam, Cornelius Krasel, Michelle L Halls, Mark Connor, J Robert Lane, Stefan Schulz, Macdonald J Christie, Meritxell Canals
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Science signaling 13 (625) (2020)
Zoe A Stephenson, Robert F Harvey, Kenneth R Pryde, Sarah Mistry, Rachel E Hardy, Riccardo Serreli, Injae Chung, Timothy Eh Allen, Mark Stoneley, Marion MacFarlane, Peter M Fischer, Judy Hirst, Barrie Kellam, Anne E Willis
Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I. eLife 9 (2020)
Tim J Fyfe, Barrie Kellam, David A Sykes, Ben Capuano, Peter J Scammells, J Robert Lane, Steven J Charlton, Shailesh N Mistry
Structure-Kinetic Profiling of Haloperidol Analogues at the Human Dopamine D2 Receptor. Journal of medicinal chemistry 62 (21) (2019)
Sean Conroy, Nicholas D Kindon, Jacqueline Glenn, Leigh A Stoddart, Richard J Lewis, Stephen J Hill, Barrie Kellam, Michael J Stocks
Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925. Journal of medicinal chemistry 61 (7) (2018)
Tim J Fyfe, Barbara Zarzycka, Herman D Lim, Barrie Kellam, Shailesh N Mistry, Vsevolod Katritch, Peter J Scammells, J Robert Lane, Ben Capuano
A Thieno[2,3- d]pyrimidine Scaffold Is a Novel Negative Allosteric Modulator of the Dopamine D2 Receptor. Journal of medicinal chemistry 62 (1) (2018)
Francesca Citossi, Thomas Smith, Jong Bong Lee, Joel Segal, Pavel Gershkovich, Michael J Stocks, Tracey D Bradshaw, Barrie Kellam, Maria Marlow
Self-Assembling Benzothiazole-Based Gelators: A Mechanistic Understanding of in Vitro Bioactivation and Gelation. Molecular pharmaceutics 15 (4) (2018)
Raymond Lam, Arisbel B Gondin, Meritxell Canals, Barrie Kellam, Stephen J Briddon, Bim Graham, Peter J Scammells
Fluorescently Labeled Morphine Derivatives for Bioimaging Studies. Journal of medicinal chemistry 61 (3) (2018)
Sean Conroy, Nicholas D Kindon, Jacqueline Glenn, Leigh A Stoddart, Richard J Lewis, Stephen J Hill, Barrie Kellam, Michael J Stocks
Correction to Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925. Journal of medicinal chemistry 61 (9) (2018)
Abigail L Emtage, Shailesh N Mistry, Peter M Fischer, Barrie Kellam, Charles A Laughton
GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors. Journal of biomolecular structure & dynamics 35 (12) (2016)

Barrie Kellam.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Barrie Kellam